(210) | Number of the EPO application | 17700391 |
(220) | Filing date of the EPO application | 2017.01.04 |
(80) | EPO patent specification publication (B) | EPB nr. 10/2022, 2022.03.09 |
(110) | EPO patent number | 3397622 |
(21) | Number of the application | e 2018 1100 |
(71) | Name(s) of applicant(s), code of the country | ObsEva S.A., CH; |
(72) | Name(s) of inventor(s), code of the country | NAXOS PAGE Patrick, CH; SCHWARZ Matthias, CH; JORAND-LEBRUN Catherine, FR; QUATTROPANI Anna, CH; POMEL Vincent, FR; LOUMAYE Ernest, CH; POHL Oliver, CH; GOTTELAND Jean-Pierre, CH; |
(73) | Name(s) of owner(s), code of the country | ObsEva S.A., CH; |
(54) | Title of the invention | CO-ADMINISTRATION OF ALPHA-AMINO ESTER OF HYDROXYPROPYLTHIAZOLIDINE CARBOXAMIDE DERIVATIVE AND A TOCOLYTIC AGENT |
(13) | Kind-of-document code | A1 |
(51) | International Patent Classification | A61K 31/426 (2006.01.01); A61K 31/4422 (2006.01.01); A61K 38/095 (2019.01.01); A61K 38/12 (2006.01.01); A61K 45/06 (2006.01.01); A61P 15/00 (2006.01.01); A61P 15/06 (2006.01.01) |
(19) | Country | CH |
(41) | Date of publication of the application | 2018.12.31 |
(30) | Priority | 201614987586, 2016.01.04, US; 201662274674 P, 2016.01.04, US; 201662395664 P, 2016.09.16, US; 201662407918 P, 2016.10.13, US |
(86) | International application | PCT/EP2017/050099, 2017.01.04 |
(87) | International publication | WO 2017/118639, 2017.07.13 |